152 related articles for article (PubMed ID: 20189428)
21. [Radiobiological characteristics of a medical proton beam of 1000 MeV energy].
Konnov BA; Komarov EI; Kozhina TN; Nizkovolos VB; Karlin DL
Med Radiol (Mosk); 1977 Jul; 22(7):33-40. PubMed ID: 909365
[No Abstract] [Full Text] [Related]
22. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.
Guerrero M; Li XA; Ma L; Linder J; Deyoung C; Erickson B
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):933-9. PubMed ID: 15936580
[TBL] [Abstract][Full Text] [Related]
23. A new method of creating minibeam patterns for synchrotron radiation therapy: a feasibility study.
Prezado Y; Renier M; Bravin A
J Synchrotron Radiat; 2009 Jul; 16(Pt 4):582-6. PubMed ID: 19535874
[TBL] [Abstract][Full Text] [Related]
24. TCP and NTCP in preclinical and clinical research in Europe.
Baumann M; Petersen C; Krause M
Rays; 2005; 30(2):121-6. PubMed ID: 16294904
[TBL] [Abstract][Full Text] [Related]
25. Radiation damage to protein specimens from electron beam imaging and diffraction: a mini-review of anti-damage approaches, with special reference to synchrotron X-ray crystallography.
Massover WH
J Synchrotron Radiat; 2007 Jan; 14(Pt 1):116-27. PubMed ID: 17211078
[TBL] [Abstract][Full Text] [Related]
26. Number of patients potentially eligible for proton therapy.
Glimelius B; Ask A; Bjelkengren G; Björk-Eriksson T; Blomquist E; Johansson B; Karlsson M; Zackrisson B
Acta Oncol; 2005; 44(8):836-49. PubMed ID: 16332591
[TBL] [Abstract][Full Text] [Related]
27. Differences between biological effects of high LET and low LET radiations in relation to their application in radiotherapy.
Barendsen GW
Radiol Clin (Basel); 1977; 46(5):380-9. PubMed ID: 601222
[TBL] [Abstract][Full Text] [Related]
28. [The hadron therapy project].
Amaldi U; Arduini G; Cambria R; Canzi C; Furetta C; Leone R; Rossi S; Silari M; Tosi G; Vecchi L
Radiol Med; 1993 Nov; 86(5):669-79. PubMed ID: 8272553
[TBL] [Abstract][Full Text] [Related]
29. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system.
Lehmann J; Hartmann Siantar C; Wessol DE; Wemple CA; Nigg D; Cogliati J; Daly T; Descalle MA; Flickinger T; Pletcher D; Denardo G
Phys Med Biol; 2005 Mar; 50(5):947-58. PubMed ID: 15798267
[TBL] [Abstract][Full Text] [Related]
30. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
31. Uncertainties in physical and biological targeting with radiation therapy.
Cox JD; Schechter NR; Lee AK; Forster K; Stevens CW; Ang KK; Komaki R; Liao Z; Milas L
Rays; 2003; 28(3):211-5. PubMed ID: 15018309
[TBL] [Abstract][Full Text] [Related]
32. [Radiobiological assessment of the effect of radiation therapy of tumors].
Zholkiver KI
Med Radiol (Mosk); 1983 Jul; 28(7):33-5. PubMed ID: 6877058
[TBL] [Abstract][Full Text] [Related]
33. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
Marcu LG
Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
[TBL] [Abstract][Full Text] [Related]
34. [Conformal radiation therapy. Fédération nationale des centres de lutte contre le cancer (FNCLCC)].
Carrie C; Ginestet C; Bey P; Aletti P; Haie-Meder C; Briot E; Resbeut M; Coste G; Chauvel P; Brassard N
Bull Cancer; 1995; 82(5):325-30. PubMed ID: 7626839
[TBL] [Abstract][Full Text] [Related]
35. Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study.
Cho SH
Phys Med Biol; 2005 Aug; 50(15):N163-73. PubMed ID: 16030374
[TBL] [Abstract][Full Text] [Related]
36. Microbeam radiation therapy: tissue dose penetration and BANG-gel dosimetry of thick-beams' array interlacing.
Dilmanian FA; Romanelli P; Zhong Z; Wang R; Wagshul ME; Kalef-Ezra J; Maryanski MJ; Rosen EM; Anschel DJ
Eur J Radiol; 2008 Dec; 68(3 Suppl):S129-36. PubMed ID: 18606516
[TBL] [Abstract][Full Text] [Related]
37. Three-dimensional treatment planning and conformal radiation dose delivery.
Lichter AS; Ten Haken RK
Important Adv Oncol; 1995; ():95-109. PubMed ID: 7672816
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
39. Application of constant vs. variable relative biological effectiveness in treatment planning of intensity-modulated proton therapy.
Frese MC; Wilkens JJ; Huber PE; Jensen AD; Oelfke U; Taheri-Kadkhoda Z
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):80-8. PubMed ID: 20382482
[TBL] [Abstract][Full Text] [Related]
40. New treatment modalities in radiation therapy.
Holland J
J Intraven Nurs; 2001; 24(2):95-101. PubMed ID: 11836839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
